Aligos Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Aligos Therapeutics using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-11-06 | $-3.07 | $-2.16 | -42.1 % |
Jun 2024 | 2024-08-06 | $0.75 | $-4.00 | 118.8 % |
Mar 2024 | 2024-05-07 | $-5.50 | $-4.75 | -15.8 % |
Dec 2023 | 2024-03-12 | $-5.50 | $-6.75 | 18.5 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-11-06 | $1.27M | $330.00K | 284.6 % |
Dec 2023 | 2024-03-12 | $2.01M | $1.60M | 25.6 % |
Sep 2023 | 2023-11-02 | $2.15M | $2.50M | -13.8 % |
Dec 2022 | 2023-03-09 | $3.54M | $1.72M | 105.6 % |
Aligos Therapeutics ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 6, 2024 for Q3.
Aligos Therapeutics ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 6, 2024 for Q3 and the Actual EPS was $-3.07, which missed the estimate of $-2.16.
Aligos Therapeutics ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 6, 2024 for Q3 and the Actual EPS was {{actualEPS}}, which beat the estimate of {{estEPS}}.
Browse earnings estimates, EPS, and revenue on all stocks.